ReviewBiomolecules & biomedicine2023

Targeting toll-like receptor 4 (TLR4) and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy.

Chao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.